首页 | 本学科首页   官方微博 | 高级检索  
检索        

益气养阴扶正固本法治疗中晚期非小细胞肺癌临床观察
引用本文:刘雅妮,徐静,王文平,徐武清.益气养阴扶正固本法治疗中晚期非小细胞肺癌临床观察[J].辽宁中医学院学报,2009(11):122-123.
作者姓名:刘雅妮  徐静  王文平  徐武清
作者单位:宁夏医科大学,宁夏银川750004
摘    要:目的:探讨益气养阴、扶正固本法治疗晚期非小细胞肺癌的临床疗效。方法:将60例患者随机分成两组,治疗组(中药加化疗)30例,对照组(单纯化疗)30例,分别治疗8周。结果:①治疗组与对照组比较在改善临床症状方面有明显差异fP〈0.05)。②治疗组与对照组比较治疗组可以明显提高生存质量(P〈0.05)。③两纽肿瘤缓解率比较:两组无明显差异(P〉0.05),疾病控制率比较,治疗组与对照组有明显差异(P〈0.05)。结论:益气养阴、扶正固本法联合化疗治疗晚期非小细胞肺癌比单纯化疗治疗有明显的优势。

关 键 词:益气养阴  挟正固本  晚期非  细胞肺癌  中医药疗法

Therapeutic Effect of Yiqiyangyin Fuzhengguben Decoction in Treating Advanced Non-Small Lung Cancer
Institution:LIU Yani, XU Jing, WANG Wen-ping ( Ningxia Medical University,. Yinc.huan 750004, Ningxia. China )
Abstract:Objective-To investigate the clinical therapeutic effect of Yiqiyangyin fuzhengguben decoction in treating patients with advanced non-small lung cancer(NSCLC).Methods: 60 patients were divided randomly into two groups: the 30 patients treated with Yiqiyangyin fuzhengguben decoction and chemotherapy(group A),the other 30 patients treated with chemotherapy .alone(group. B).The efficacy was evaluated after 8 weeks. Results: There are significant advantages in improving the clinical symptom between group A and group B(P〈0.5). (2)The group A has significant advantages than group B in improving the quality of life (P〈0.05).(3)there are significant differences about disease control rates between group A and group B (P〉0.05),but there are no significant differences Comparing two groups of tumor response rate(P〈0.05). Conclusion: It shows, obvious, advantages in yiqiyangin fuzhengguben, decoction combination chemotherapy.
Keywords:yiqiyangyin fuzhengguben decoction  NSCLC  traditional Chinese therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号